Natera shares its earnings for the second quarter of 2026, including the full call transcript.

Oct 12, 2026, 6:19 AM ETResultsRead the original at Benzinga

Good for NTRA

Natera reported record test volume, 38% sales growth, and a higher full-year sales range. Signatera approvals and cash inflow outweigh ongoing operating losses and a 65% gross margin below its goal of more than 70%.

NTRA · Natera Inc.

AI read · Good for NTRA

The AI's read

More tests and sales, along with new Signatera approvals, give Natera room to grow. The company also reported cash coming in and smaller operating losses. There are still concerns. About 65 cents of each sales dollar remained after direct costs, below its long-run goal of more than 70 cents, and operating losses continued. The growth, approvals, and higher sales range carry more weight.

Get alerts for NTRA

Follow Natera Inc. (NTRA) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for NTRA

Free on the App Store and Google Play, or on the web.